The Tohoku Journal of Experimental Medicine
Online ISSN : 1349-3329
Print ISSN : 0040-8727
ISSN-L : 0040-8727
LAV/HTLV-III Antibodies in Patients Treated with Intravenous Gammaglobulins
TADASHI KANOHTATSUHARU OHNONORIMUNE FUNAKOSHIHIROSHI FUJIITAKAMICHI OKADA
Author information
JOURNAL FREE ACCESS

1986 Volume 150 Issue 3 Pages 361-362

Details
Abstract
KANOH, T., OHNO, T., FUNAKOSHI, N., FUJII, H. and OKADA, T. LAV/HTLV-III Antibodies in Patients Treated with Intravenous Gammaglobulins. Tohoku J. exp. Med., 1986, 150 (3), 361-362-The test sera from 50 patients treated with intravenous gammaglobulins (IVG) were examined for LAV/HTLV-III antibody by ELISA tests in order to evaluate the risk of transmission of LAV/HTLV-III virus via administration of IVG. The three ELISA-positive sera were negative for the antibody by both indirect immunofluorescence assay (IFA) and Western blot assay (WBA). Thus, all of the test sera were negative for LAV/HTLV-III antibody. Two of the ELISA-positive/IFA-negative/WBA-negative samples had HLA-DR4 antibodies causing positive ELISA results.
Content from these authors
© Tohoku University Medical Press
Previous article Next article
feedback
Top